MLTX - CIK 0001821586
MoonLake Immunotherapeutics has filed 296 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (67 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2022-05-05 | 2022-04-06 |
| Insider trade | 4 | 2022-05-05 | 2022-04-06 |
| S-1/A | - | 2022-05-02 | - |
| Activist ownership stake | SC 13D | 2022-04-18 | - |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| New insider ownership | 3 | 2022-04-15 | 2022-04-05 |
| Major company event | 8-K | 2022-04-11 | 2022-04-05 |
| Insider trade | 4 | 2022-04-07 | 2022-04-05 |
| Insider trade | 4 | 2022-04-07 | 2022-04-05 |
| Major company event | 8-K | 2022-03-31 | 2022-03-31 |
| Proxy materials | DEFA14A | 2022-03-25 | - |
| 425 | - | 2022-03-24 | - |
| Major company event | 8-K | 2022-03-24 | 2022-03-21 |
| Proxy materials | DEFA14A | 2022-03-24 | - |
| S-1/A | - | 2022-03-14 | - |
| S-1/A | - | 2022-03-08 | - |
| DEFR14A | - | 2022-03-04 | - |
| Proxy materials | DEFA14A | 2022-02-25 | - |
| Major company event | 8-K | 2022-02-25 | 2022-02-20 |
| Annual report | 10-K | 2022-02-17 | 2021-12-31 |
| DEFM14A | - | 2022-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2022-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2022-02-14 | - |
| Company correspondence | CORRESP | 2022-02-11 | - |
| PRER14A | - | 2022-02-11 | - |
| IPO registration | S-1 | 2022-02-11 | - |
| SEC correspondence | UPLOAD | 2022-02-11 | - |
| SEC correspondence | UPLOAD | 2022-02-10 | - |
| Company correspondence | CORRESP | 2022-02-03 | - |
| PRER14A | - | 2022-02-03 | - |
| Passive ownership stake (update) | SC 13G/A | 2022-02-03 | - |
| SEC correspondence | UPLOAD | 2022-02-02 | - |
| PRER14A | - | 2022-01-21 | - |
| Company correspondence | CORRESP | 2022-01-20 | - |
| Proxy materials | DEFA14A | 2022-01-19 | - |
| SEC correspondence | UPLOAD | 2022-01-12 | - |
| SEC correspondence | UPLOAD | 2022-01-12 | - |
| PRER14A | - | 2021-12-16 | - |
| Company correspondence | CORRESP | 2021-12-15 | - |
| Company correspondence | CORRESP | 2021-12-14 | - |
| Quarterly report (amended) | 10-Q/A | 2021-12-14 | 2021-09-30 |
| Annual report (amended) | 10-K/A | 2021-12-14 | 2020-12-31 |